A07EC01 • sulfasalazine • Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents
Sulfasalazine is a medication primarily used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, as well as rheumatoid arthritis. It is an anti-inflammatory and immunomodulatory agent that helps reduce inflammation and alleviate symptoms of these conditions.
In inflammatory bowel diseases, sulfasalazine is effective in inducing and maintaining remission, reducing symptoms like diarrhea, abdominal pain, and rectal bleeding. In rheumatoid arthritis, it is used to reduce joint pain, stiffness, and inflammation.
Common side effects include nausea, headaches, skin rashes, and gastrointestinal disturbances. In rare cases, it may cause severe allergic reactions, a decrease in blood cell counts, or liver function impairment.
Sulfasalazine should be used with caution in patients allergic to sulfonamides or salicylates. Regular monitoring of liver function and blood counts is important during treatment.
Substance: sulfasalazine
Date of last drug list: 01-07-2013
Commercial code: W05751001
Concentration: 500mg
Pharmaceutical form: tablets
Quantity: 50
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.